Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New drug approvals for 2022: Synthesis and clinical applications
Shuo Yuan, Dandan Shen, Rui Jia, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 2352-2391
Closed Access | Times Cited: 18

Showing 18 citing articles:

Annual review of PROTAC degraders as anticancer agents in 2022
Xiao Wang, Zhao-Long Qin, Na Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 267, pp. 116166-116166
Closed Access | Times Cited: 52
A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
Weixin Zhang, Jiao Huang, Xin-Yi Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115673-115673
Closed Access | Times Cited: 20
Design, synthesis and biological evaluation of 1,2,3-triazole benzothiazole derivatives as tubulin polymerization inhibitors with potent anti-esophageal cancer activities
Bowen Wu, Wenjing Huang, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116118-116118
Closed Access | Times Cited: 7
A comprehensive review of small molecule drugs approved by the FDA in 2023: Advances and prospects
Yi‐Ru Bai, Dong‐Jie Seng, Ying Xu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116706-116706
Closed Access | Times Cited: 6
Sulfone Electrophiles in Cross-Electrophile Coupling: Nickel-Catalyzed Difluoromethylation of Aryl Bromides
K. Benjamin, Samantha Gavin, Benjamin N. Ahern, et al.
ACS Catalysis (2024) Vol. 14, Iss. 14, pp. 11087-11100
Closed Access | Times Cited: 5
Thienopyrimidine: A promising scaffold in the development of kinase inhibitors with anticancer activities
Yunhe Liu, Ziyue Wang, Yifei Du, et al.
Bioorganic & Medicinal Chemistry (2025), pp. 118109-118109
Closed Access
A comprehensive review of small molecule drugs approved by the FDA in 2024: Advance and prospect
Yi‐Ru Bai, Qingchuan Duan, Dong‐Jie Seng, et al.
Chinese Chemical Letters (2025), pp. 111025-111025
Closed Access
Design, synthesis and biological evaluation of novel 2,4-diaminopyrimidine cinnamyl derivatives as inhibitors of FAK with potent anti-gastric cancer activities
Yang Liu, Lijun Kong, Na Li, et al.
Bioorganic Chemistry (2023) Vol. 141, pp. 106895-106895
Closed Access | Times Cited: 9
A comprehensive review of new small molecule drugs approved by the FDA in 2022: Advance and prospect
Yi‐Ru Bai, Xin Yang, Ken Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116759-116759
Closed Access | Times Cited: 3
N-Benzyl arylamide derivatives as novel and potent tubulin polymerization inhibitors against gastric cancers: Design, structure–activity relationships and biological evaluations
Jian Song, Shenghui Wang, Qiu-Ge Liu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 109678-109678
Closed Access | Times Cited: 2
Sulfone Electrophiles in Cross-Electrophile Coupling: Nickel-Catalyzed Difluoromethylation of Aryl Bromides
Benjamin Chi, Samantha Gavin, Benjamin N. Ahern, et al.
(2024)
Open Access | Times Cited: 2
Discovery of novel pyrazolo[1,5-a]pyrimidine derivatives as potent reversal agents against ABCB1-mediated multidrug resistance
Xiang-Jing Fu, Na Li, Ji Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116761-116761
Closed Access | Times Cited: 2
Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities
Xin-Yi Tian, Weixin Zhang, Jia Yu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 265, pp. 116079-116079
Closed Access | Times Cited: 5
Methodological and regulatory aspects of pharmaceutical development of biological products
Д. В. Куркин, Е. И. Морковин, Д. А. Бакулин, et al.
Pharmacy & Pharmacology (2024) Vol. 11, Iss. 5, pp. 384-398
Open Access | Times Cited: 1
Synthesis and biological evaluation of 4-phenyl-5-quinolinyl substituted isoxazole analogues as potent cytotoxic and tubulin polymerization inhibitors against ESCC
Meiqi Jia, Yuanyuan Pei, Na Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116611-116611
Closed Access | Times Cited: 1
The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer
Yi‐Ru Bai, Weiguang Yang, Rui Jia, et al.
Medicinal Research Reviews (2024) Vol. 45, Iss. 1, pp. 214-273
Closed Access
The mechanism of action and chemical synthesis of FDA newly approved drug molecules
Dandan Shen, Yuelin Zhang, Xiang Li, et al.
Drug Development Research (2024) Vol. 85, Iss. 6
Closed Access
Unveiling terahertz wave stress effects and mechanisms in Pinellia ternata: Challenges, insights, and future directions
Dongdong Wang, Jiatong Zheng, Surendra Sarsaiya, et al.
Physiologia Plantarum (2024) Vol. 176, Iss. 1
Closed Access
Page 1

Scroll to top